Skip to content

Salvequick Blister Prevention Heels&Toes

by Orkla Wound Care AB 2 variants

Ref 602236

Expiring European Union

CE MDR

Valid until

7 Feb 2027

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier Intertek Medical Notified Body AB

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number28620123341-03 Date20 Aug 2026IssuedStatusExpiring expires 7 Feb 2027

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • 28620123341-03 Expiring Supplemented Expires in 98 days

    Quality management system EU MDR

    Issued
    20 Aug 2026
    Expires
    7 Feb 2027
    Reason
    Other

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Expiring

Specification

EUDAMED

Device Name
Td 20
Model / Reference
602236
Primary DI / UDI-DI
07310616022369
Basic UDI-DI
73402100200035
EMDN Code
M04040301 Hydrocolloid dressings, non-combined
Device Class
Class IIa
EU market of registration
Sweden

Manufacturer details

EUDAMED SRN
SE-MF-000021041

Other devices from Orkla Wound Care AB

See all devices from Orkla Wound Care AB →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No